RESMED CUFS Aktie

>RESMED CUFS Aktienkurs

19.25 EUR (TradegateBSX)

Ask: 19.7 EUR / 120 Stück

Bid: 18.8 EUR / 120 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

RESMED CUFS Aktie über LYNX handeln

Intraday

1 Jahr

>RESMED CUFS Performance

1 Woche: +1,3%

1 Monat: -11,7%

3 Monate: -6,6%

6 Monate: -18,4%

1 Jahr: -3,5%

laufendes Jahr: -6,6%

>RESMED CUFS Aktie

Name:

RESMED CUFS/10 DL-,004

Land:

Australien

Sektor:

Gesundheit

ISIN/ Wkn:

AU000000RMD6 / 935168

Symbol/ Ticker:

RMEA (Frankfurt)

Kürzel:

FRA:RMEA, ETR:RMEA, RMEA:GR

Index:

Webseite:

https://investor.resmed.c..

Profil:

ResMed Inc. Chess Depositary Interest represents equity ownership in ResMed Inc., a global leader in digital health and medical devices, specifically targeting respiratory care and sleep disorders. Issued as Chess Depositary Interests (CDIs) in Austr..
>Volltext..

Marktkapitalisierung:

28124.41 Mio. EUR

Unternehmenswert:

27622.8 Mio. EUR

Umsatz:

4838.67 Mio. EUR

EBITDA:

1874.2 Mio. EUR

Nettogewinn:

1332.39 Mio. EUR

Gewinn je Aktie:

0.91 EUR

Schulden:

734.83 Mio. EUR

Liquide Mittel:

1228.36 Mio. EUR

Operativer Cashflow:

1736.29 Mio. EUR

Bargeldquote:

1.14

Umsatzwachstum:

20.84%

Gewinnwachstum:

31.27%

Dividende je Aktie:

0.2 EUR

Dividendenrendite:

1.09%

Dividendenschätzung:

Div. Historie:

11.02.26 - 0.050573997€
12.11.25 - 0.05175€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

RESMED CUFS, RESMED

Letzte Datenerhebung:

05.04.26

>RESMED CUFS Kennzahlen

Aktien/ Unternehmen:

Aktien: 1456.78 Mio. St.

Frei handelbar: 100%

Leerverk. Aktien: -

Rückkaufquote: 1.35%

Mitarbeiter: 10600

Umsatz/Mitarb.: 0.43 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 57.57%

Bewertung:

KGV: 18.78

KGV lG: 17.77

KUV: 4.93

KBV: 4.53

PEG-Ratio: 0.81

EV/EBITDA: 14.74

Rentabilität:

Bruttomarge: 59.99%

Gewinnmarge: 27.54%

Operative Marge: 34.17%

Managementeffizenz:

Gesamtkaprendite: 18.98%

Eigenkaprendite: 25.66%

>RESMED CUFS Peer Group

Gesundheit, Neurologische- & psychische Behandlung/ Medizin, Medizinprodukte & -technik/ Implantate/ Wundpflege

>RESMED CUFS Chart & Kurs - Tradegate

>RESMED CUFS News

01.04.26 - 22:09

Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026 (GlobeNewswire EN)

SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2026 on Thursday, April 30, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast....

30.03.26 - 15:42	ResMed Earnings Preview: What to Expect (Barchart)
	Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...

18.03.26 - 03:00	With global populations ageing, are ResMed shares a good buy today? (Fool)
	A leading expert delivers his verdict on the outlook for ResMed shares. The post With global populations ageing, are ResMed shares a good buy today? appeared first on The Motley Fool Australia....

18.03.26 - 01:48	Why Cochlear and ResMed shares could be strong buys (Fool)
	Wilsons has given its verdict on these big names and it's good. The post Why Cochlear and ResMed shares could be strong buys appeared first on The Motley Fool Australia....

17.03.26 - 18:45	ResMed (RMD) Upgraded to Buy: Here′s What You Should Know (Zacks)
	ResMed (RMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....

17.03.26 - 17:01	Is Resmed Stock the Right Pick for Your Portfolio Now? (Zacks)
	RMD expands mask and device sales while maintaining strong liquidity, but macro and competitive pressures loom....

16.03.26 - 04:36	What are analysts saying about ResMed, Downer, and Nuix shares? (Fool)
	They have given their verdicts on these shares. Are they bullish or bearish? Here's what you need to know. The post What are analysts saying about ResMed, Downer, and Nuix shares? appeared first on The Motley Fool Australia....

12.03.26 - 13:00	Is ResMed Stock Underperforming the Nasdaq? (Barchart)
	Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...

10.03.26 - 20:00	3 Reasons Not to Sleep on ResMed Stock (Fool)
	ResMed is a leader in CPAP machines and other medical devices that help millions breathe better....

04.03.26 - 21:36	Here′s How Much You Would Have Made Owning ResMed Stock In The Last 10 Years (Benzinga)
	Importance Rank: 1 read more...

03.03.26 - 09:03	Resmed′s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach (GlobeNewswire EN)
	Resmed's Global Sleep Survey of 30,000 people shows sleep is a top health priority, yet quality rest remains out of reach for many worldwide....

25.02.26 - 09:12	Why I would buy ResMed and these quality blue chips now (Fool)
	I think these blue chips are best buys and worth considering this week. The post Why I would buy ResMed and these quality blue chips now appeared first on The Motley Fool Australia....

24.02.26 - 15:06	Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana (GlobeNewswire EN)
	Resmed will open a new distribution center in Greenwood, Indiana to expand U.S. operations and further serve patients and providers across North America....

18.02.26 - 17:30	ResMed Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
	Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...

10.02.26 - 11:30	Zacks.com featured highlights include Amphenol, GE Aerospace, ResMed and Ameriprise Financial (Zacks)
	Amphenol stands out among new GARP picks as acquisitions, AI-driven demand and margin expansion set the stage for solid 2026 growth....

06.02.26 - 16:00	RMD Stock Up Following Q2 Earnings & Revenue Beat, Margins Expand (Zacks)
	Resmed shares rise after Q2 EPS and revenues beat expectations, with the gross and operating margins expanding sharply across core segments....

06.02.26 - 02:12	Why Brambles, HMC Capital, ResMed, and Rio Tinto shares are rising today (Fool)
	These shares are avoiding the selloff and are pushing higher on Friday. The post Why Brambles, HMC Capital, ResMed, and Rio Tinto shares are rising today appeared first on The Motley Fool Australia....

04.02.26 - 23:12	Buy, hold, sell: Credit Corp, PLS, and ResMed shares (Fool)
	Let's see what Morgans is saying about these shares this week. The post Buy, hold, sell: Credit Corp, PLS, and ResMed shares appeared first on The Motley Fool Australia....

04.02.26 - 22:12	What can investors expect from ResMed, Cochlear and CSL shares this reporting season? (Fool)
	Here's updated analysis on three of Australia's largest healthcare stocks. The post What can investors expect from ResMed, Cochlear and CSL shares this reporting season? appeared first on The Motley Fool Australia....

03.02.26 - 19:45	Zacks Industry Outlook Highlights Boston Scientific, ResMed, Phibro Animal Health and BioLife Solutions (Zacks)
	Medical device leaders counter tariff pressures with innovation, as AI adoption and aging demographics support long-term growth....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Notwendigkeit ist bei weitem stärker als die Kunst. - Aischylos

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram